|
Mutation Information
|
Mutation Site
|
W28* |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
PreC |
|
Amino acid_Mutation
|
G1896A |
|
Genotype/Subtype
|
D |
Literature Information
|
PubMed PMID
|
17438047
|
|
Published Year
|
2007 |
|
Journal
|
Antimicrobial agents and chemotherapy |
|
Title
|
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. |
|
Author
|
Warner N,Locarnini S,Kuiper M,Bartholomeusz A,Ayres A,Yuen L,Shaw T |
|
Evidence
|
Polymerase mutants were created in both HBeAg-positive and HBeAg-negative backgrounds. HBeAg negativity was produced by site-directed mutagenesis to generate the G1896A mutation (pcW28*) (5).
|
|
|
HBV Mutation Detail Information